What if doctors could edit the DNA inside your cells to cure a genetic disease? What if farmers could grow crops that survive drought by tweaking a single gene? CRISPR-Cas9 has turned these possibilities into reality, giving scientists a precise tool for rewriting the code of life.
Imagine scientists discovered a way to rewrite the DNA of any living organism as easily as editing a sentence on a computer.
Now answer: If you could change one thing about your own DNA, what would it be and why? Should scientists be allowed to edit human embryos? Who should get to decide what changes are acceptable?
Gene editing means making precise changes to the DNA sequence inside a cell — turning a gene off, fixing a mutation, or even inserting a new sequence. Unlike older methods that were slow, expensive and imprecise, modern gene-editing tools can target a single location in the genome with remarkable accuracy.
The most famous gene-editing tool is CRISPR-Cas9. Its name comes from a natural defence system found in bacteria, which use it to recognise and slice up viral DNA. Scientists have repurposed this bacterial machinery into a programmable editing tool.
At Stage 5, you need to understand CRISPR-Cas9 in simple terms:
Think of it like editing a document: the guide RNA is "Find," Cas9 is "Cut," and the cell's repair system is "Paste" — but with the potential to paste in a corrected version.
Gene editing is already transforming medicine, agriculture and conservation. Here are three key areas:
Disease treatment
Scientists are using CRISPR to treat genetic diseases by correcting the faulty genes that cause them. In 2023, the first CRISPR-based therapy was approved in several countries for sickle cell disease, a painful and life-threatening condition caused by a single mutation in the haemoglobin gene. Doctors extract a patient's blood stem cells, edit them with CRISPR in the lab, and return them to the patient. Clinical trials are also exploring CRISPR therapies for certain cancers, where immune cells are edited to better recognise and attack tumours.
Crop improvement
Farmers and scientists are using gene editing to develop crops with improved yields, better nutrition and resistance to pests or environmental stress. In Australia, researchers at CSIRO have used gene-editing techniques to develop wheat and barley varieties with enhanced drought tolerance and disease resistance. Unlike traditional genetic modification, which often inserts genes from other species, gene editing can make small, precise changes within a plant's own DNA — changes that could theoretically occur through natural mutation.
Conservation and pest control
Researchers have proposed using CRISPR to create gene drives — genetic changes that spread rapidly through wild populations. One idea is to modify mosquitoes so they cannot carry the malaria parasite, potentially saving hundreds of thousands of lives each year. Another proposal targets invasive species in Australia, such as using gene drives to control feral cat or cane toad populations. However, these applications raise serious ecological concerns.
Despite its power, CRISPR-Cas9 is not perfect. Scientists must weigh significant limitations and ethical concerns before applying it.
Off-target effects
The guide molecule is designed to match one specific DNA sequence, but the genome is enormous — over 3 billion base pairs in humans. Sometimes the guide molecule binds to a similar but unintended sequence and Cas9 cuts there instead. This is called an off-target effect. An accidental cut in the wrong gene could disrupt an important function or even trigger cancer. Researchers are working hard to improve guide design and test for off-target changes, but the risk cannot be completely eliminated yet.
Ethical concerns
Editing somatic cells (body cells like blood or skin) affects only the individual being treated. But editing germline cells (sperm, eggs or embryos) means the changes would be passed on to all future generations. This raises profound ethical questions: Who decides which genetic changes are acceptable? Could gene editing create inequalities between those who can afford enhancements and those who cannot? Should we ever use it for purposes other than treating disease — for example, to increase height or intelligence?
In Australia, germline editing for reproductive purposes is illegal under the Prohibition of Human Cloning for Reproduction Act 2002. Somatic gene therapy is permitted under strict regulatory oversight by the Office of the Gene Technology Regulator (OGTR) and the Therapeutic Goods Administration (TGA).
Australian regulatory oversight of gene technology is among the most rigorous in the world. The Office of the Gene Technology Regulator (OGTR), based in Canberra, assesses all genetically modified organisms before they can be released. CSIRO, Australia's national science agency, conducts extensive gene-editing research on crops and livestock but must obtain OGTR approval for any field trials. In 2019, Australian researchers at the University of Queensland used CRISPR to develop a rapid diagnostic test for COVID-19, demonstrating how the same technology can be applied outside of gene editing itself. The National Health and Medical Research Council (NHMRC) oversees ethical guidelines for human gene therapy research, ensuring that Australian scientists operate within internationally accepted boundaries.
Wrong: "CRISPR can perfectly edit any gene with no mistakes."
Right: CRISPR is precise but not perfect. Off-target effects remain a significant challenge. Scientists must carefully validate each edit and consider unintended consequences before clinical or environmental use.
Wrong: "Gene editing and genetic modification are exactly the same thing."
Right: Genetic modification typically involves inserting DNA from another species. Gene editing makes precise changes within an organism's existing DNA and does not necessarily add foreign genes.
Sickle cell disease affects approximately 100,000 people in the United States and millions worldwide, including Aboriginal and Torres Strait Islander populations in Australia where prevalence is higher than in the general community. The disease is caused by a single DNA mutation that changes one amino acid in haemoglobin.
In 2023, regulators in the UK and USA approved Casgevy (exagamglogene autotemcel), the world's first CRISPR-based medicine. The treatment works by editing blood stem cells to reactivate production of fetal haemoglobin, compensating for the defective adult haemoglobin. For patients who have endured a lifetime of pain crises and organ damage, this represents a potential cure — not just management — of their genetic disease. The approval marked a historic milestone: humanity had moved from reading the genetic code to rewriting it therapeutically.
1 Scientists use CRISPR to edit blood stem cells from a patient with sickle cell disease, enabling them to produce healthy red blood cells. Identify one benefit and one limitation of this approach.
2 Australian researchers develop a gene-edited wheat variety that survives with 30% less water. Explain one benefit to Australian farmers and one potential concern about releasing this wheat into the environment.
3 A research team proposes using CRISPR to make Australian feral cats sterile, so their population declines over time. Identify one potential benefit and one significant risk of this approach.
1 Explain how selective breeding and CRISPR gene editing both aim to improve traits, but achieve this in fundamentally different ways.
2 Genetic modification (GM) often involves inserting a gene from one species into another. Gene editing can make precise changes without adding foreign DNA. Explain why some people view gene editing as more acceptable than GM, even though both alter an organism's DNA.
3 A scientist claims that because gene editing is more precise than selective breeding, it should replace traditional breeding methods entirely. Evaluate this claim, considering at least one advantage of selective breeding that CRISPR cannot easily replicate.
1. What is CRISPR-Cas9?
2. Which of the following is a potential application of CRISPR?
3. A scientist uses CRISPR to edit a gene in a plant, but accidentally changes a nearby gene too. What is this called?
4. Why is editing human embryos with CRISPR particularly controversial?
5. A researcher proposes using CRISPR to make mosquitoes unable to carry malaria. What is a potential risk?
6. Describe how CRISPR-Cas9 works in simple terms. What makes it different from older genetic technologies? 4 MARKS
7. Choose one application of CRISPR (disease treatment, agriculture, or conservation). Explain the potential benefit and one limitation. 4 MARKS
8. Compare CRISPR to selective breeding and genetic modification. How are they similar and how do they differ? 4 MARKS
Go back to your Think First responses at the top of the lesson.
1. Sickle cell therapy: Benefit — can potentially cure a life-threatening genetic disease rather than just managing symptoms [1 mark]. Limitation — the treatment is extremely expensive, requires specialised medical facilities, and may not be accessible to all patients who need it [1 mark].
2. Drought-resistant wheat: Benefit — Australian farmers could maintain yields during droughts, improving food security and farm income [1 mark]. Environmental concern — the edited wheat might cross-breed with wild relatives or alter soil microbiome interactions in unpredictable ways [1 mark].
3. Sterile feral cats: Benefit — could reduce the devastating impact of feral cats on Australia's native wildlife, which kill billions of animals annually [1 mark]. Risk — the gene drive could spread to non-target species or have cascading ecological effects that are difficult to predict or reverse [1 mark].
1. Selective breeding chooses parents with desirable traits and relies on natural genetic recombination during reproduction [1 mark]. CRISPR directly alters DNA sequences in a laboratory, bypassing generations of breeding and achieving precise, predictable changes [1 mark].
2. Gene editing makes changes within an organism's own DNA without necessarily adding foreign genetic material [1 mark]. This means the resulting organism might have a genetic profile that could theoretically arise through natural mutation, which some people find more acceptable than combining DNA from different species [1 mark].
3. The claim is overstated [1 mark]. Selective breeding has safely improved crops and livestock for thousands of years without laboratory intervention, and it often improves multiple traits simultaneously through natural polygenic variation [1 mark]. CRISPR is powerful for single-gene changes but does not easily replicate the complex, coordinated improvements that selective breeding can achieve across many genes [1 mark]. Both tools have roles in modern agriculture.
1. B — CRISPR-Cas9 is a tool for making precise changes to DNA. It is not an antibiotic, sequencing method or cloning technique.
2. C — CRISPR is being used to treat genetic diseases like sickle cell anaemia by correcting the faulty gene in a patient's cells.
3. A — An off-target effect occurs when CRISPR cuts DNA at an unintended location, potentially disrupting another gene.
4. D — Editing embryos (germline editing) is controversial because the genetic changes would be inherited by all descendants.
5. B — Releasing gene-edited mosquitoes could have unexpected effects on food webs, predator-prey relationships and ecosystem balance.
Q6 (4 marks): CRISPR-Cas9 uses a guide RNA molecule to locate a specific DNA sequence [1 mark]. The Cas9 enzyme then cuts the DNA at that precise location [1 mark]. The cell's natural repair machinery fixes the break, and scientists can direct this repair to make a desired change [1 mark]. Unlike older technologies such as selective breeding (which is slow and indirect) or genetic modification (which inserts foreign DNA), CRISPR can make precise, targeted changes directly at a specific gene [1 mark].
Q7 (4 marks): Example answer — disease treatment: CRISPR can be used to treat sickle cell disease by editing blood stem cells so they produce healthy haemoglobin [1 mark]. The potential benefit is that patients could be cured of a painful, life-shortening genetic disease rather than just managing symptoms [1 mark]. One limitation is that the treatment is currently very expensive and requires highly specialised medical facilities, making it inaccessible to many patients globally [1 mark]. Additionally, off-target effects could cause unintended changes to other genes [1 mark].
Q8 (4 marks): All three technologies aim to improve the traits of organisms [1 mark]. Selective breeding achieves this by choosing which organisms reproduce, without directly altering DNA [1 mark]. Genetic modification inserts genes from other species into an organism's genome [1 mark]. CRISPR gene editing makes precise changes within an organism's existing DNA, allowing specific genes to be altered, removed or corrected without necessarily adding foreign genetic material [1 mark].
Test your knowledge of gene editing, CRISPR-Cas9 and genetic technologies in this fast-paced quiz battle. Correct answers power your attacks!
Climb platforms using your knowledge of CRISPR, gene editing and genetic technologies. Pool: Lesson 9.
Tick when you have finished all activities and checked your answers.